Valuation: EUROAPI

Market Cap 119M 136M 110M 102M 193M 13.02B 197M 1.32B 517M 6.4B 512M 501M 22.15B P/E 2026 *
-1.57x
P/E 2027 * -2.96x
Enterprise Value 77.7M 88.83M 71.66M 66.3M 126M 8.48B 128M 858M 336M 4.16B 333M 326M 14.42B EV / Sales 2026 *
0.1x
EV / Sales 2027 * 0.15x
Free-Float
65.03%
Yield 2026 *
-
Yield 2027 * -
1 day-1.26%
1 week-6.18%
Current month-5.19%
1 month-1.02%
3 months-1.08%
6 months-41.51%
Current year-44.28%
1 week 1.24
Extreme 1.238
1.38
1 month 1.23
Extreme 1.23
1.38
Current year 1.23
Extreme 1.23
2.26
1 year 1.23
Extreme 1.23
3.41
3 years 1.23
Extreme 1.23
12.96
5 years 1.23
Extreme 1.23
18.92
10 years 1.23
Extreme 1.23
18.92
Manager TitleAgeSince
Chief Executive Officer - 2024-12-08
Director of Finance/CFO - 2024-10-16
Compliance Officer - 2023-11-26
Director TitleAgeSince
Director/Board Member 62 2022-05-05
Director/Board Member - 2022-05-05
Chairman 57 2024-12-08
Change 5-day change 1-year change 3-year change Capi.($)
-0.63%-6.18% - - 136M
+0.04%+0.06%+54.35%+168.03% 1,084B
-1.46%-1.29%+66.14%+62.78% 634B
-1.27%-4.54%+30.75%+85.31% 447B
+0.18%-1.76%+29.04%+26.48% 330B
-6.22%-8.14%+28.87%+31.18% 295B
-1.27%-2.91%+27.42%+44.91% 285B
-0.93%-3.57%-27.74%-39.70% 218B
-1.43%-3.04%+22.34%+61.42% 199B
-1.53%+1.78%+17.98%+76.52% 169B
Average -1.52%+2.52%+27.68%+57.44% 406.65B
Weighted average by Cap. -1.19%+2.48%+38.78%+83.95%

Financials

2026 *2027 *
Net sales 760M 869M 701M 649M 1.23B 82.98B 1.25B 8.4B 3.29B 40.75B 3.26B 3.19B 141B 782M 893M 721M 667M 1.27B 85.28B 1.29B 8.63B 3.38B 41.88B 3.35B 3.28B 145B
Net income -75.7M -86.54M -69.81M -64.59M -123M -8.26B -125M -836M -328M -4.06B -325M -318M -14.05B -40.25M -46.01M -37.12M -34.35M -65.19M -4.39B -66.28M -445M -174M -2.16B -173M -169M -7.47B
Net Debt -41.66M -47.62M -38.42M -35.55M -67.47M -4.55B -68.6M -460M -180M -2.23B -179M -175M -7.73B -5.06M -5.79M -4.67M -4.32M -8.2M -552M -8.34M -55.92M -21.92M -271M -21.73M -21.26M -940M
Logo EUROAPI
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 5 production sites located in France (2), Germany, Italy and Hungary.
Employees
2,961
Date Price Change Volume
26-07-09 1.261 -0.63% 0
26-07-08 €1.254 -2.03% 4,861
26-07-07 €1.280 -4.33% 1,871
26-07-06 €1.338 -1.18% 108,626
26-07-03 €1.354 +0.74% 256
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
4
Last Close Price
1.254EUR
Average target price
1.475EUR
Spread / Average Target
+17.62%

Quarterly revenue - Rate of surprise